Pleiotropic effects of statins and their clinical significance

被引:82
作者
LaRosa, JC [1 ]
机构
[1] SUNY Hlth Sci Ctr, Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
关键词
D O I
10.1016/S0002-9149(01)01643-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a community-based population of patients with acute myocardial infarction (AMI), we sought to: (1) determine the prevalence of bundle branch block (BBB) on the presenting electrocardiogram (ECG), (2) compare the clinical characteristics and the treatment administered to patients with and without BBB, and (3) determine the association of BBB with mortality. We analyzed the admission ECGs of 894 consecutive patients with AMI from Olmsted County, Minnesota, seen at our institution from January 1988 to March 1998. Of these, 53 had left BBB (LBBB) (5.9%) and 60 had right BBB (RBBB) (6.7%). Patients with BBB were more likely to be older, have a history of AMI or hypertension, and to be in Killip class >1 at presentation. They were less likely to receive primary reperfusion therapy, beta blockers, or heparin, but more likely to receive angiotensin-converting enzyme inhibitors. They had lower mean predischarge ejection fractions (38 +/- 16% vs 50 +/- 15%, p <0.0001). In-hospital mortality was 13.3%, 17.0%, and 9.1% for patients with RBBB, LBBB, and no BBB, respectively (p = 0.11). Respective postdischarge survival at 1, 3, and 5 years was 80%,60%, and 50% in the RBBB group, 78%, 56%, and 51% in the LBBB group, and 92%, 85%, and 76% in the group without BBB (p <0.0001). Although BBB was not an independent predictor of mortality on multivariate analysis, the presence of transient or persistent BBB with AMI is an easily recognized clinical marker of increased mortality. Our conclusion from this study is that in a community-based population, patients who had LBBB or RBBB at the time of AMI had lower predischarge ejection fractions and higher in-hospital and long-term unadjusted mortality. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:291 / +
页数:96
相关论文
共 24 条
[1]   Cholesterol, stroke risk, and stroke prevention [J].
Ansell B.J. .
Current Atherosclerosis Reports, 2000, 2 (2) :92-96
[2]   Direct vascular effects of HMG-CoA reductase inhibitors [J].
Bellosta, S ;
Bernini, F ;
Ferri, N ;
Quarato, P ;
Canavesi, M ;
Arnaboldi, L ;
Fumagalli, R ;
Paoletti, R ;
Corsini, A .
ATHEROSCLEROSIS, 1998, 137 :S101-S109
[3]   REQUIREMENT FOR MEVALONATE IN ACETYLATED LDL INDUCTION OF CHOLESTEROL ESTERIFICATION IN MACROPHAGES [J].
BERNINI, F ;
DIDONI, G ;
BONFADINI, G ;
BELLOSTA, S ;
FUMAGALLI, R .
ATHEROSCLEROSIS, 1993, 104 (1-2) :19-26
[4]   Vastatins inhibit tissue factor in cultured human macrophages - A novel mechanism of protection against atherothrombosis [J].
Colli, S ;
Eligini, S ;
Lalli, M ;
Camera, M ;
Paoletti, R ;
Tremoli, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) :265-272
[5]   Lipids and the endothelium [J].
Dart, AM ;
Chin-Dusting, JPF .
CARDIOVASCULAR RESEARCH, 1999, 43 (02) :308-322
[6]   Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects [J].
Davignon, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (8A) :17F-23F
[7]   Low-density lipoprotein-independent effects of statins [J].
Davignon, J ;
Laaksonen, R .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (06) :543-559
[8]   Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? [J].
Faggiotto A. ;
Paoletti R. .
Current Atherosclerosis Reports, 2000, 2 (1) :20-25
[9]   Effects of estrogen replacement on the progression of coronary-artery atherosclerosis [J].
Herrington, DM ;
Reboussin, DM ;
Brosnihan, KB ;
Sharp, PC ;
Shumaker, SA ;
Snyder, TE ;
Furberg, CD ;
Kowalchuk, GJ ;
Stuckey, TD ;
Rogers, WJ ;
Givens, DH ;
Waters, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08) :522-529
[10]   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613